(Q51690302)

English

The role of ace gene polymorphism in the development of angioedema secondary to angiotensin converting enzyme inhibitors and angiotensin II receptor blockers.

scientific article published in May 2008

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

9 April 2018

http://europepmc.org/abstract/MED/18680700

The role of ace gene polymorphism in the development of angioedema secondary to angiotensin converting enzyme inhibitors and angiotensin II receptor blockers. (English)

1 reference

Europe PubMed Central

PubMed publication ID

9 April 2018

http://europepmc.org/abstract/MED/18680700

author name string

Gulec M

1

1 reference

Europe PubMed Central

PubMed publication ID

9 April 2018

http://europepmc.org/abstract/MED/18680700

Caliskaner Z

2

1 reference

Europe PubMed Central

PubMed publication ID

9 April 2018

http://europepmc.org/abstract/MED/18680700

Tunca Y

3

1 reference

Europe PubMed Central

PubMed publication ID

9 April 2018

http://europepmc.org/abstract/MED/18680700

Ozturk S

4

1 reference

Europe PubMed Central

PubMed publication ID

9 April 2018

http://europepmc.org/abstract/MED/18680700

Bozoglu E

5

1 reference

Europe PubMed Central

PubMed publication ID

9 April 2018

http://europepmc.org/abstract/MED/18680700

Gul D

6

1 reference

Europe PubMed Central

PubMed publication ID

9 April 2018

http://europepmc.org/abstract/MED/18680700

Erel F

7

1 reference

Europe PubMed Central

PubMed publication ID

9 April 2018

http://europepmc.org/abstract/MED/18680700

Kartal O

8

1 reference

Europe PubMed Central

PubMed publication ID

9 April 2018

http://europepmc.org/abstract/MED/18680700

Karaayvaz M

9

1 reference

Europe PubMed Central

PubMed publication ID

9 April 2018

http://europepmc.org/abstract/MED/18680700

publication date

1 May 2008

1 reference

Europe PubMed Central

PubMed publication ID

9 April 2018

http://europepmc.org/abstract/MED/18680700

Allergologia et Immunopathologia

1 reference

Europe PubMed Central

PubMed publication ID

9 April 2018

http://europepmc.org/abstract/MED/18680700

36

1 reference

Europe PubMed Central

PubMed publication ID

9 April 2018

http://europepmc.org/abstract/MED/18680700

3

1 reference

Europe PubMed Central

PubMed publication ID

9 April 2018

http://europepmc.org/abstract/MED/18680700

134-140

1 reference

Europe PubMed Central

PubMed publication ID

9 April 2018

http://europepmc.org/abstract/MED/18680700

Angioedema associated with angiotensin-converting enzyme inhibitor use: outcome after switching to a different treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2808%2972537-0

7 January 2021

based on heuristic

inferred from DOI database lookup

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2808%2972537-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Vasopeptidase inhibition: a double-edged sword?

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2808%2972537-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Renin-angiotensin system blockade at the level of the angiotensin converting enzyme or the angiotensin type-1 receptor: similarities and differences

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2808%2972537-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Fresh-frozen plasma as a treatment for life-threatening ACE-inhibitor angioedema

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2808%2972537-0

7 January 2021

based on heuristic

inferred from DOI database lookup

ACE inhibitor-induced angioedema. Incidence, prevention and management

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2808%2972537-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Angiotensin-converting enzyme inhibitors as a cause of unilateral tongue angioedema in a 68-year-old woman

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2808%2972537-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Increased C-reactive protein in ACE-inhibitor-induced angioedema

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2808%2972537-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Delayed diagnosis of angiotensin-converting enzyme (ACE) inhibitor induced angioedema and urticaria

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2808%2972537-0

7 January 2021

based on heuristic

inferred from DOI database lookup

An evaluation of risk factors for adverse drug events associated with angiotensin-converting enzyme inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2808%2972537-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Dipeptidyl peptidase IV activity in patients with ACE-inhibitor-associated angioedema

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2808%2972537-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Bradykinin and the pathophysiology of angioedema

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2808%2972537-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Plasma bradykinin in angio-oedema.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2808%2972537-0

7 January 2021

based on heuristic

inferred from DOI database lookup

A variant in XPNPEP2 is associated with angioedema induced by angiotensin I-converting enzyme inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2808%2972537-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Angiotensin-converting enzyme inhibitor-associated angioedema is characterized by a slower degradation of des-arginine(9)-bradykinin

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2808%2972537-0

7 January 2021

based on heuristic

inferred from DOI database lookup

The kallikrein-kinin system: current and future pharmacological targets.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2808%2972537-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Angiotensin-converting enzyme gene polymorphism in Behçet's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2808%2972537-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Increased deformability of red blood cells is associated with a deletion polymorphism of the angiotensin-converting enzyme gene.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2808%2972537-0

7 January 2021

based on heuristic

inferred from DOI database lookup

ACE polymorphisms

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2808%2972537-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacogenetic interactions between beta-blocker therapy and the angiotensin-converting enzyme deletion polymorphism in patients with congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2808%2972537-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Angiotensin-converting enzyme I/D polymorphism and hypertension: the Ohasama study

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2808%2972537-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Angiotensin-Converting Enzyme Insertion/Deletion Genotype, Exercise, and Physical Decline

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2808%2972537-0

7 January 2021

based on heuristic

inferred from DOI database lookup

QT dispersion and left ventricular hypertrophy in athletes: relationship with angiotensin-converting enzyme I/D polymorphism

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2808%2972537-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Angiotensin-I converting enzyme gene polymorphism in Turkish type 2 diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2808%2972537-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Angiooedema and urticaria with angiotensin converting enzyme inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2808%2972537-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Angioedema due to ACE inhibitors: increased risk in patients of African origin

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2808%2972537-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Predictors of airway intervention in angioedema of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2808%2972537-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Angioedema induced by angiotensin II blocker telmisartan

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2808%2972537-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Angioedema associated with angiotensin II receptor antagonists: challenging our knowledge of angioedema and its etiology.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2808%2972537-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Angioedema due to valsartan

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2808%2972537-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Can angiotensin receptor antagonists be used safely in patients with previous ACE inhibitor-induced angioedema?

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2808%2972537-0

7 January 2021

based on heuristic

inferred from DOI database lookup

[Angioedema and angiotensin converting enzyme inhibitors: a report of 19 cases]

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2808%2972537-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0301-0546(08)72537-0

1 reference

Europe PubMed Central

PubMed publication ID

9 April 2018

http://europepmc.org/abstract/MED/18680700

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 April 2018

http://europepmc.org/abstract/MED/18680700

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51690302&oldid=1405178097"